Literature DB >> 7502418

Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure.

S C Cozad1, S R Smalley, M Austenfeld, M Noble, S Jennings, R Raymond.   

Abstract

OBJECTIVES: To identify recurrence patterns and possible indications for adjuvant treatment.
METHODS: Ninety-four patients with transitional cell carcinoma of the renal pelvis or ureter were reviewed to determine their pattern of failure. Factors including gender and age, tumor stage and grade, and extent of surgical procedure and adjuvant radiation therapy (RT) were analyzed with respect to local and distant recurrence and survival.
RESULTS: Seventy-seven patients had resections without residual. On multivariate analysis, grade (P = 0.01) and adjuvant RT (P = 0.02) had significant effects on local control. Metastases were solely dependent on stage (P = 0.0001). Survival was dependent on stage (P = 0.0059) and age (P = 0.036), with the use of adjuvant RT of borderline significance (P = 0.07). Twenty-seven patients were excluded from local failure and survival analysis; of these, 3 died within 1 month of surgery, 5 had metastasis at presentation, and 19 had local disease that was unresectable. Eleven of these 19 were treated by RT, resulting in 2 long-term disease-free survivors after receiving doses of 45 and 50.4 Gy.
CONCLUSIONS: In patients with adverse factors, such as high grade or stage, close margins, or positive nodes, local control can be improved with adjuvant radiation. Improvement in survival is of borderline significance on multivariate analysis, with approximately 50% of high stage or grade patients developing metastasis.

Entities:  

Mesh:

Year:  1995        PMID: 7502418     DOI: 10.1016/S0090-4295(99)80346-X

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

1.  Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy.

Authors:  Kalyan C Latchamsetty; Christopher R Porter
Journal:  Rev Urol       Date:  2006

Review 2.  Perioperative chemotherapy for upper tract urothelial cancer.

Authors:  Ajjai S Alva; Surena F Matin; Seth P Lerner; Arlene O Siefker-Radtke
Journal:  Nat Rev Urol       Date:  2012-04-10       Impact factor: 14.432

3.  Human epidermal growth factor receptor 2 expression in urothelial carcinoma of the renal pelvis: correlation with clinicopathologic parameters.

Authors:  Laleh Ehsani; Adeboye O Osunkoya
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Preoperative hydronephrosis and diabetes mellitus predict poor prognosis in upper urinary tract urothelial carcinoma.

Authors:  Insang Hwang; Seung Il Jung; Deok-Hyun Nam; Eu Chang Hwang; Taek Won Kang; Dong Deuk Kwon; Soo Bang Ryu
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

5.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

6.  Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.

Authors:  C-F Wu; K-F Ng; C-S Chen; P-L Chang; C-K Chuang; W-H Weng; S-K Liao; S-T Pang
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

7.  Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse.

Authors:  Bing Chen; Zhao-Chong Zeng; Guo-Min Wang; Li Zhang; Zong-Ming Lin; Li-An Sun; Tong-Yu Zhu; Li-Li Wu; Jian-Ying Zhang; Yuan Ji
Journal:  BMC Cancer       Date:  2011-07-14       Impact factor: 4.430

8.  Comprehensive management of upper tract urothelial carcinoma.

Authors:  Georgios Koukourakis; Georgios Zacharias; Michael Koukourakis; Kiriaki Pistevou-Gobaki; Christos Papaloukas; Athanasios Kostakopoulos; Vassilios Kouloulias
Journal:  Adv Urol       Date:  2008-12-10

9.  Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter.

Authors:  Shilajit D Kundu; Scott E Eggener
Journal:  Adv Urol       Date:  2009-01-26

10.  Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy.

Authors:  Kang Su Cho; Hyun Min Choi; Kyochul Koo; Sung Jin Park; Koon Ho Rha; Young Deuk Choi; Byung Ha Chung; Nam Hoon Cho; Seung Choul Yang; Sung Joon Hong
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.